TY - JOUR AU - Saltz, L. B. AU - Cox, J. V. AU - Blanke, C. PY - 2000 DA - 2000// TI - Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200009283431302 DO - 10.1056/NEJM200009283431302 ID - Saltz2000 ER - TY - JOUR AU - Delaunoit, T. AU - Goldberg, R. M. AU - Sargent, D. J. PY - 2004 DA - 2004// TI - Mortality associated with daily bolus 5- fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741 JO - Cancer VL - 101 UR - https://doi.org/10.1002/cncr.20594 DO - 10.1002/cncr.20594 ID - Delaunoit2004 ER - TY - JOUR AU - Tournigand, C. AU - Andre, T. AU - Achille, E. PY - 2004 DA - 2004// TI - FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.113 DO - 10.1200/JCO.2004.05.113 ID - Tournigand2004 ER - TY - JOUR AU - Grothey, A. AU - Sargent, D. J. AU - Richard, M. PY - 2004 DA - 2004// TI - Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.11.037 DO - 10.1200/JCO.2004.11.037 ID - Grothey2004 ER - TY - JOUR AU - Ohtsu, A. AU - Baba, H. AU - Sakata, Y. PY - 2000 DA - 2000// TI - Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group JO - Br J Cancer VL - 83 UR - https://doi.org/10.1054/bjoc.2000.1236 DO - 10.1054/bjoc.2000.1236 ID - Ohtsu2000 ER - TY - JOUR AU - Shirao, K. AU - Ohtsu, A. AU - Takeda, H. PY - 2004 DA - 2004// TI - Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma JO - Cancer VL - 100 UR - https://doi.org/10.1002/cncr.20277 DO - 10.1002/cncr.20277 ID - Shirao2004 ER - TY - JOUR AU - Komatsu, Y. AU - Yuuki, S. AU - Fuse, N. PY - 2005 DA - 2005// TI - Phase II study of oral S-1 plus irinotecan in patients with advanced colorectal cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302 JO - Jpn J Clin Oncol VL - 35 UR - https://doi.org/10.1093/jjco/hyi025 DO - 10.1093/jjco/hyi025 ID - Komatsu2005 ER - TY - JOUR AU - Kanthan, R. AU - Loewy, J. AU - Kanthan, S. C. PY - 1999 DA - 1999// TI - Skeletal metastases in colorectal carcinomas: a Saskatchewan profile JO - Dis Colon Rectum VL - 42 UR - https://doi.org/10.1007/BF02236213 DO - 10.1007/BF02236213 ID - Kanthan1999 ER - TY - JOUR AU - Katoh, M. AU - Unakami, M. AU - Hara, M. PY - 1995 DA - 1995// TI - Bone metastasis from colorectal cancer in autopsy cases JO - J Gastroenterol VL - 30 UR - https://doi.org/10.1007/BF02367787 DO - 10.1007/BF02367787 ID - Katoh1995 ER - TY - JOUR AU - De Gramont, A. AU - Bosset, J. F. AU - Milan, C. PY - 1997 DA - 1997// TI - Randomized trial comparing monthly low dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study JO - J Clin Oncol VL - 15 ID - De Gramont1997 ER - TY - JOUR AU - Kohne, C. H. AU - Wils, J. AU - Lorenz, M. PY - 2003 DA - 2003// TI - Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952 JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.11.122 DO - 10.1200/JCO.2003.11.122 ID - Kohne2003 ER - TY - JOUR AU - Sakata, Y. AU - Ohtsu, A. AU - Horikoshi, N. PY - 1998 DA - 1998// TI - Late Phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur-0,4M gimestat-1M otastat potassium) in advanced gastric cancer patients JO - Eur J Cancer VL - 34 UR - https://doi.org/10.1016/S0959-8049(98)00211-1 DO - 10.1016/S0959-8049(98)00211-1 ID - Sakata1998 ER - TY - JOUR AU - Sugimachi, K. AU - Maehara, Y. AU - Horikoshi, N. PY - 1999 DA - 1999// TI - An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group JO - Oncology VL - 57 UR - https://doi.org/10.1159/000012032 DO - 10.1159/000012032 ID - Sugimachi1999 ER - TY - JOUR AU - Ogawa, M. PY - 1999 DA - 1999// TI - Novel anticancer drugs in Japan JO - J Cancer Res Clin Oncol VL - 125 UR - https://doi.org/10.1007/s004320050255 DO - 10.1007/s004320050255 ID - Ogawa1999 ER - TY - JOUR AU - Kawahara, M. AU - Furuse, K. AU - Segawa, Y. PY - 2001 DA - 2001// TI - Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer JO - Br J cancer VL - 85 UR - https://doi.org/10.1054/bjoc.2001.2031 DO - 10.1054/bjoc.2001.2031 ID - Kawahara2001 ER - TY - JOUR AU - Douillard, J. Y. AU - Hoff, P. M. AU - Skillings, J. R. PY - 2002 DA - 2002// TI - Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.04.123 DO - 10.1200/JCO.2002.04.123 ID - Douillard2002 ER - TY - CHAP AU - Douillard, J. Y. AU - Hoff, P. M. AU - Skillings, J. R. PY - 2004 DA - 2004// TI - UFT/LV combination based regimens with oxaliplatin or irinotecan as first line treatment for patients (pts) with non resectable metastatic colorectal cancer (MCRC): Results of two multicentric phase II trials BT - Proc ASCO ID - Douillard2004 ER - TY - CHAP PY - 2005 DA - 2005// BT - Clinical Practice Guidelines in Oncology Version 4 ID - ref18 ER -